Gleason Score News and Research

RSS
Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

Increased radiation dose offers survival benefit for men with medium- and high-risk prostate cancer

Decipher genomic analysis platform predicts tumor responsiveness to neoadjuvant chemotherapy in MIBC patients

Decipher genomic analysis platform predicts tumor responsiveness to neoadjuvant chemotherapy in MIBC patients

Decipher Prostate Cancer Classifier predicts metastasis in patients treated with salvage radiation therapy

Decipher Prostate Cancer Classifier predicts metastasis in patients treated with salvage radiation therapy

Researchers discover new gene subgroup that drives prostate cancer

Researchers discover new gene subgroup that drives prostate cancer

Research may offer new targets for diagnosing, treating advanced prostate cancer

Research may offer new targets for diagnosing, treating advanced prostate cancer

New studies to improve prostate cancer detection to be presented at AUA annual meeting

New studies to improve prostate cancer detection to be presented at AUA annual meeting

Active surveillance appears to be safer management strategy for prostate cancer patients

Active surveillance appears to be safer management strategy for prostate cancer patients

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

Novel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate cancer recurrence

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

Palmetto GBA issues positive coverage policy for GenomeDx's Decipher prostate cancer test

Palmetto GBA issues positive coverage policy for GenomeDx's Decipher prostate cancer test

Researchers identify biomarker that can predict GS7 prostate cancer patients

Researchers identify biomarker that can predict GS7 prostate cancer patients

Prostate biopsy method impacts cancer risk profile

Prostate biopsy method impacts cancer risk profile

ProMark test for prostate cancer meets primary endpoint

ProMark test for prostate cancer meets primary endpoint

Vitamin D deficiency predicts prostate biopsy outcomes

Vitamin D deficiency predicts prostate biopsy outcomes

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

Men with chronic inflammation in non-cancerous prostate tissue may have nearly twice risk of prostate cancer

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Invasive 3D mapping biopsies detect ultrasound-guided biopsies miss prostate cancers

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

Myriad Genetics' Prolaris opens door to a new era of personalized treatment for prostate cancer

Nomogram predicts overdiagnosis in prostate cancer screening

Nomogram predicts overdiagnosis in prostate cancer screening

Higher levels of physical activity reduces risk of prostate cancer recurrence, mortality

Higher levels of physical activity reduces risk of prostate cancer recurrence, mortality